Level Chart

Basic Info

Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago.

Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 57.19B
Latest Period 2023
Last Updated Jan 31 2024, 08:41 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 21.17%
Value from 1 Year Ago 98.99B
Change from 1 Year Ago -42.23%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 57.19B
December 31, 2022 98.99B
December 31, 2021 79.56B
December 31, 2020 40.72B
December 31, 2019 38.01B
December 31, 2018 0.00
Date Value
December 31, 2017 0.00
December 31, 2016 0.00
December 31, 2015 0.00
December 31, 2014 0.00
December 31, 2013 0.00
December 31, 2012 0.00

Basic Info

Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago.

Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 57.19B
Latest Period 2023
Last Updated Jan 31 2024, 08:41 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 21.17%
Value from 1 Year Ago 98.99B
Change from 1 Year Ago -42.23%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
PFE Pfizer Inc 0.30%